Volop kansen voor farmaceutische bedrijven in arme landen
Henk Snyders reports on the 2016 Access to Medicine Index, with a focus on affordability of medicines (article in Dutch).
Date
14 November 2016
Pharmaceutical companies only a limited number of poor countries, with a small number of products. That appears Monday in a ranking of twenty pharmaceutical companies about the availability of their medicines in 106 low- and middle-income countries. "There are still clear opportunities for the pharmaceutical industry to expand," the compilers of the so-called Access to Medicine Index, which appears every two years. (...)